Conditional disruption of calpain in the CNS alters dendrite morphology, impairs LTP, and promotes neuronal survival following injury

J Neurosci. 2013 Mar 27;33(13):5773-84. doi: 10.1523/JNEUROSCI.4247-12.2013.

Abstract

Ubiquitous classical (typical) calpains, calpain-1 and calpain-2, are Ca(+2)-dependent cysteine proteases, which have been associated with numerous physiological and pathological cellular functions. However, a clear understanding of the role of calpains in the CNS has been hampered by the lack of appropriate deletion paradigms in the brain. In this study, we describe a unique model of conditional deletion of both calpain-1 and calpain-2 activities in mouse brain, which more definitively assesses the role of these ubiquitous proteases in brain development/function and pathology. Surprisingly, we show that these calpains are not critical for gross CNS development. However, calpain-1/calpain-2 loss leads to reduced dendritic branching complexity and spine density deficits associated with major deterioration in hippocampal long-term potentiation and spatial memory. Moreover, calpain-1/calpain-2-deficient neurons were significantly resistant to injury induced by excitotoxic stress or mitochondrial toxicity. Examination of downstream target showed that the conversion of the Cdk5 activator, p35, to pathogenic p25 form, occurred only in the presence of calpain and that it played a major role in calpain-mediated neuronal death. These findings unequivocally establish two central roles of calpain-1/calpain-2 in CNS function in plasticity and neuronal death.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
  • Age Factors
  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Biophysics
  • Brain Injuries / chemically induced
  • Brain Injuries / metabolism*
  • Brain Injuries / pathology*
  • Brain Injuries / physiopathology
  • Brain* / embryology
  • Brain* / growth & development
  • Brain* / pathology
  • Bromodeoxyuridine / metabolism
  • Calpain / deficiency*
  • Cell Death / drug effects
  • Cell Death / genetics
  • Dendrites / metabolism
  • Dendrites / pathology
  • Dendrites / ultrastructure
  • Disease Models, Animal
  • Electric Stimulation
  • Embryo, Mammalian
  • Evoked Potentials / drug effects
  • Evoked Potentials / physiology
  • Excitatory Amino Acid Agonists / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / genetics
  • Female
  • Gene Expression Regulation, Developmental / genetics
  • Green Fluorescent Proteins / genetics
  • Hippocampus / cytology
  • In Vitro Techniques
  • Intermediate Filament Proteins / genetics
  • Intermediate Filament Proteins / metabolism
  • Long-Term Potentiation / genetics
  • Long-Term Potentiation / physiology*
  • Male
  • Maze Learning / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • N-Methylaspartate / pharmacology
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Nestin
  • Neurons / cytology
  • Neurons / metabolism
  • Patch-Clamp Techniques
  • Phosphotransferases
  • Psychomotor Performance
  • RNA, Messenger / metabolism
  • Silver Staining
  • Transfection
  • Tyrosine 3-Monooxygenase / genetics
  • Tyrosine 3-Monooxygenase / metabolism
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / pharmacology

Substances

  • Cdk5r1 protein, mouse
  • Excitatory Amino Acid Agonists
  • Intermediate Filament Proteins
  • Nerve Tissue Proteins
  • Nes protein, mouse
  • Nestin
  • RNA, Messenger
  • neuronal Cdk5 activator (p25-p35)
  • Green Fluorescent Proteins
  • N-Methylaspartate
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Tyrosine 3-Monooxygenase
  • Phosphotransferases
  • Calpain
  • Capns1 protein, mouse
  • Capn2 protein, mouse
  • Bromodeoxyuridine